Developer docs
API playgroundTry for free, no card

Search company profiles

Board of Radiation & Isotope Technologies

Full company profile

uuid0034w2y

Namestring
Board of Radiation & Isotope Technologies
Legal namestring
Board of Radiation & Isotope Technology
Websiteurl
britatom.gov.in
Company typeenum
Private
Founded yearint
1989
Descriptiontext

Board of Radiation & Isotope Technology (BRIT) is an independent unit of India's Department of Atomic Energy (DAE), headquartered within the BARC complex in Navi Mumbai. Established in 1989, BRIT is the premier Indian government organization producing radiation and isotope-based products and services across four primary verticals: healthcare, agriculture, research, and industry. Its core product portfolio includes radiopharmaceuticals (PET, SPECT, and therapeutic formulations such as I-131, Lu-177 PSMA-617, Lu-177 DOTA-TATE), sealed radiation sources (cobalt-60 teletherapy, brachytherapy, radiography, and irradiator sources), radiation technology equipment (gamma chambers, blood irradiators, radiography cameras), radiochemicals, radioimmunoassay kits, labelled compounds, dosimeters, and biological indicators.

BRIT's production infrastructure is anchored by the RAPPCOF facility in Kota — India's only site with a complete cobalt-60 sealed source production cycle from reactor to finished product — the ISOMED gamma radiation processing plant (recently upgraded as ISOMED 2.0, commercial from May 2025), and the Medical Cyclotron Facility (Cyclone-30) at Kolkata commissioned in 2019. The organization operates six regional centers (Bengaluru, Delhi, Dibrugarh, Hyderabad, Kolkata, Kota) providing nationwide distribution of time-sensitive radiopharmaceuticals and on-site customer support, alongside an online ordering portal and the BRIT Bandhu mobile application.

BRIT's business model is hybrid: it sells radiopharmaceuticals, sealed sources, and radiation equipment as one-time purchases to hospitals, cancer centers, blood banks, research institutions, and industrial customers; and provides fee-based services including medical product sterilization, food irradiation, calibration, dosimetry, and consultancy. All sales require AERB regulatory authorization through the eLORA system, creating a regulatory moat that effectively makes BRIT the sole compliant domestic supplier. The organization holds international certifications (ISO/ASTM 51205, ANSI N433.1, ISO-3999, ISO 11137, US Pharmacopoeia) and participates in IAEA coordinated research programs. Customers include Tata Memorial Centre, Dr. Bhubaneswar Borooah Cancer Institute, food processors, and 1,500+ institutional buyers across India, with cobalt-60 sealed sources also exported internationally.

Short descriptiontext

BRIT is an independent unit of India's Department of Atomic Energy producing radiopharmaceuticals, sealed radiation sources, gamma processing services, and radiation equipment for healthcare, agriculture, research, and industrial customers across India and select international markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersMumbai, India
HQ citystring
Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiopharmaceutical manufacturing, sealed radiation sources, gamma radiation processing, radiation technology equipment, nuclear medicine products
Industry9 codes
1Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.)
CodeEUAKAIAAPrimaryYes
2Sealed Source Manufacturing, Encapsulation & Recycling/Take-Back (Source lifecycle management)
CodeEUAKAIAIPrimaryNo
3Radiation Processing & Sterilization Services (Medical device sterilization, food irradiation, materials modification)
CodeEUAKAIAGPrimaryNo
4Radiation Therapy Isotopes & Sources (Brachytherapy seeds, sealed sources for oncology)
CodeEUAKAIADPrimaryNo
5Radiation Measurement, Dosimetry & Monitoring Services (Personal/environmental dosimetry, calibration labs)
CodeEUAKAIAHPrimaryNo
6Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine)
CodeHLAIAGAJPrimaryNo
7Radiation Detection Instruments & Systems (Portal monitors, spectrometers, contamination monitors)
CodeEUAKAIAKPrimaryNo
8Radioisotope Production (Reactor/Cyclotron/Gamma)
CodeHLAIAGADPrimaryNo
9Radiopharmaceutical & Nuclear Medicine Distributors
CodeHLAIAJAIPrimaryNo
NAICS code4 codes
  • Irradiation Apparatus Manufacturing334517
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Analytical Laboratory Instrument Manufacturing334516
  • Testing Laboratories and Services54138
SIC code4 codes
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
  • Laboratory Analytical Instruments3826
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Radiopharmaceuticals and Radiation Technology Products
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Radiopharmaceutical Products
TypeOne Time License
Description

Sale of radiopharmaceuticals including PET products, SPECT products, therapeutic radiopharmaceuticals, and radiochemicals to hospitals and medical institutions

britatom.gov.in
2Sealed Radiation Sources
TypeOne Time License
Description

Manufacturing and sale of sealed radiation sources including cobalt teletherapy sources, irradiator sources, and radiography sources

britatom.gov.in
3Radiation Equipment
TypeOne Time License
Description

Sale of radiation technology equipment including gamma chambers, blood irradiators, and radiography cameras

britatom.gov.in
4Service Operations
TypeProfessional Services
Description

Sterilization of medical products, radiation processing plant services, radioanalytical laboratory services, isotope application services, EB processing services, calibration services, and dosimetry services

britatom.gov.in
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Infrastructure, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Pricing details1 tier
1Government/military
ModelOtherBilling cadencePay-as-you-go
Notes

Quote-based pricing for specialized radiation products and services. Procurement requires regulatory authorization from AERB through eLORA system for sealed sources.

britatom.gov.in
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1BRIT Bandhu
Description

Mobile application for BRIT services and information

britatom.gov.in
+3 more records
Core offering1 text field

Board of Radiation & Isotope Technology (BRIT) manufactures and supplies radiopharmaceuticals (PET, SPECT, therapeutic, radiochemical), sealed radiation sources (cobalt-60 teletherapy, irradiator, radiography, brachytherapy), and radiation technology equipment (gamma chambers, blood irradiators, radiography cameras). The organization also provides radiation-based services including medical product sterilization, radiation processing, dosimetry, calibration, and consultancy to healthcare, agriculture, research, and industrial customers across India.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1500+ customers served across India
+3 more records
Product overview1 text field

BRIT (Board of Radiation & Isotope Technology) is an independent unit of India's Department of Atomic Energy providing a comprehensive portfolio of radiation and isotope-based products and services for healthcare, agriculture, research, and industry applications. The company's offerings include: (1) Radiopharmaceuticals for PET and SPECT imaging and therapeutic applications; (2) Radio Immunoassay Kits for hormone testing; (3) Labelled Compounds (Tritium, Carbon-14, Sulphur-35) for research; (4) Sealed Sources including Cobalt Teletherapy, Irradiator, Radiography, and Brachytherapy sources; (5) Radiation Technology Equipment including Gamma Chambers (GC 5000, GC 1200), Blood Irradiators (BI 2000), and Radiography Cameras (ROLI-2, ROLI-3, COCAM-120); (6) Dosimetry products including Ceric-Cerous Dosimeters and Biological Indicators; (7) Low Level Check Sources; and (8) Various services including medical product sterilization, radiation processing, calibration, and consultancy. The company operates regional centers in Mumbai, Bengaluru, Delhi, Dibrugarh, Hyderabad, Kolkata, and Kota.

Product and service1 record
1Radiopharmaceuticals
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
1District Project Livelihood College Society, Dantewada
Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for livelihood training and skill development programs related to radiation technology applications

britatom.gov.in
Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for food processing and radiation sterilization services

Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for food irradiation and preservation services at mega food park facility

Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for food processing radiation services

Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for Radiation Processing Plant (RPP) services

Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for healthcare sector radiation services

7Green Rad
Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for radiation technology services in green/radiation applications

britatom.gov.in
Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for sterilization solutions and services

9Vishvesh Agromed Pvt. Ltd, Maharashtra
Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for agricultural and medical radiation applications

britatom.gov.in
10Hon. Balasaheb Thackeray Haridra Research and Training Center
Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for research and training in radiation technology applications

britatom.gov.in
Strategic tierMinorTypeStrategic or Co-development Partner
Description

MoU for medical equipment sterilization services

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Participation in IAEA programs including CRP projects, international conferences on radiation science and technology, and technology transfer initiatives

Strategic tierCoreTypeTechnology or Integration
Description

Hosting of Medical Cyclotron Facility (Cyclone-30) at VECC premises for production of PET and SPECT radioisotopes for Eastern India

Strategic tierCoreTypeTechnology or Integration
Description

BRIT operates within BARC complex and receives technical support and isotope production from research reactors at BARC

Strategic tierCoreTypeTechnology or Integration
Description

Regional Centre Hyderabad is located at CCMB campus for collaboration in molecular biology and biotechnology research

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Australia's national nuclear science and technology agency, operating the OPAL reactor for Mo-99 production and producing radiopharmaceuticals, sealed sources, and irradiation services. Closest structural peer to BRIT as a government-operated multi-product nuclear technology organization with healthcare, research, and industrial mandates.

TypeBroad incumbent
Description

US-based radiopharmaceutical company focused on diagnostic imaging agents including SPECT and PET products. Comparable to BRIT's diagnostic radiopharmaceutical segment serving hospitals and nuclear medicine departments.

TypeDirect peer
Description

Global nuclear medicine company producing SPECT, PET, and therapeutic radiopharmaceuticals (including Lu-177 products). Directly comparable to BRIT's radiopharmaceutical portfolio for diagnostic imaging and cancer therapy across healthcare customers.

4Institute of Radioelements (IRE)
TypeDirect peer
Description

Belgian producer of radioisotopes (Mo-99, I-131, Lu-177) for medical and industrial applications, including sealed source manufacturing. Comparable to BRIT in Mo-99/Tc-99m generator production, therapeutic radiopharmaceuticals, and sealed radiation source manufacturing for cancer treatment and industrial radiography.

TypeEmerging player
Description

US-based medical isotope producer developing Mo-99 production and therapeutic radiopharmaceuticals. Comparable to BRIT's medical radioisotope production activities for diagnostic nuclear medicine supply.

TypeBroad incumbent
Description

State-owned Chinese nuclear technology enterprise producing radiopharmaceuticals, radioactive sources, and irradiation services. Highly comparable to BRIT as a vertically integrated government-affiliated radiation technology organization serving healthcare, industry, and research within a domestic market.

TypeBroad incumbent
Description

Canadian-based global supplier of Cobalt-60 sealed sources, medical isotopes, and sterilization services. Directly comparable to BRIT's RAPPCOF cobalt source operations and ISOMED gamma sterilization, serving teletherapy and industrial radiography markets globally.

TypeEmerging player
Description

Commercial-stage radiopharma company developing Ga-68 and Lu-177 based theranostic agents for prostate, kidney, and brain cancers. Comparable to BRIT's emerging Ga-68 PET and Lu-177 PSMA-617 therapeutic portfolio as a focused theranostics competitor.

TypeDirect peer
Description

German-based manufacturer of radioisotopes, radiopharmaceuticals, and radiation technology components. Comparable to BRIT's portfolio of sealed sources, calibrated radioactive reference sources, and radiopharmaceutical precursors for medical and industrial use.

TypeDirect peer
Description

Polish national center producing radiopharmaceuticals, radioactive sources, and labelled compounds for research. Closely comparable to BRIT as a national nuclear research institute with radiopharma, sealed source, and labelled compound product lines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries9 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Board of Radiation & Isotope Technologies

Radiopharmaceuticals and Radiation Technology Productsbritatom.gov.in

BRIT is an independent unit of India's Department of Atomic Energy producing radiopharmaceuticals, sealed radiation sources, gamma processing services, and radiation equipment for healthcare, agriculture, research, and industrial customers across India and select international markets.

What Board of Radiation & Isotope Technologies does

Board of Radiation & Isotope Technology (BRIT) is an independent unit of India's Department of Atomic Energy (DAE), headquartered within the BARC complex in Navi Mumbai. Established in 1989, BRIT is the premier Indian government organization producing radiation and isotope-based products and services across four primary verticals: healthcare, agriculture, research, and industry. Its core product portfolio includes radiopharmaceuticals (PET, SPECT, and therapeutic formulations such as I-131, Lu-177 PSMA-617, Lu-177 DOTA-TATE), sealed radiation sources (cobalt-60 teletherapy, brachytherapy, radiography, and irradiator sources), radiation technology equipment (gamma chambers, blood irradiators, radiography cameras), radiochemicals, radioimmunoassay kits, labelled compounds, dosimeters, and biological indicators.

BRIT's production infrastructure is anchored by the RAPPCOF facility in Kota — India's only site with a complete cobalt-60 sealed source production cycle from reactor to finished product — the ISOMED gamma radiation processing plant (recently upgraded as ISOMED 2.0, commercial from May 2025), and the Medical Cyclotron Facility (Cyclone-30) at Kolkata commissioned in 2019. The organization operates six regional centers (Bengaluru, Delhi, Dibrugarh, Hyderabad, Kolkata, Kota) providing nationwide distribution of time-sensitive radiopharmaceuticals and on-site customer support, alongside an online ordering portal and the BRIT Bandhu mobile application.

BRIT's business model is hybrid: it sells radiopharmaceuticals, sealed sources, and radiation equipment as one-time purchases to hospitals, cancer centers, blood banks, research institutions, and industrial customers; and provides fee-based services including medical product sterilization, food irradiation, calibration, dosimetry, and consultancy. All sales require AERB regulatory authorization through the eLORA system, creating a regulatory moat that effectively makes BRIT the sole compliant domestic supplier. The organization holds international certifications (ISO/ASTM 51205, ANSI N433.1, ISO-3999, ISO 11137, US Pharmacopoeia) and participates in IAEA coordinated research programs. Customers include Tata Memorial Centre, Dr. Bhubaneswar Borooah Cancer Institute, food processors, and 1,500+ institutional buyers across India, with cobalt-60 sealed sources also exported internationally.

Board of Radiation & Isotope Technologies firmographics

Firmographics
Name
Board of Radiation & Isotope Technologies
Legal name
Board of Radiation & Isotope Technology
Website
https://britatom.gov.in
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
501–1,000 employees
Short description
BRIT is an independent unit of India's Department of Atomic Energy producing radiopharmaceuticals, sealed radiation sources, gamma processing services, and radiation equipment for healthcare, agriculture, research, and industrial customers across India and select international markets.
Ownership category
akta.pro rank

Board of Radiation & Isotope Technologies industry classification

Industry
Product category
Radiopharmaceuticals and Radiation Technology Products
NAICS
Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516), Testing Laboratories and Services (54138)
SIC
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.) (EUAKAIAA)
akta.pro secondary industries
Sealed Source Manufacturing, Encapsulation & Recycling/Take-Back (Source lifecycle management) (EUAKAIAI), Radiation Processing & Sterilization Services (Medical device sterilization, food irradiation, materials modification) (EUAKAIAG), Radiation Therapy Isotopes & Sources (Brachytherapy seeds, sealed sources for oncology) (EUAKAIAD), Radiation Measurement, Dosimetry & Monitoring Services (Personal/environmental dosimetry, calibration labs) (EUAKAIAH), Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine) (HLAIAGAJ), Radiation Detection Instruments & Systems (Portal monitors, spectrometers, contamination monitors) (EUAKAIAK), Radioisotope Production (Reactor/Cyclotron/Gamma) (HLAIAGAD), Radiopharmaceutical & Nuclear Medicine Distributors (HLAIAJAI)

Keywords

  • Radiopharmaceutical manufacturing
  • Sealed radiation sources
  • Gamma radiation processing
  • Radiation technology equipment
  • Nuclear medicine products

Where Board of Radiation & Isotope Technologies is headquartered

Location

Headquarters

HQ city
Mumbai
HQ country
India
HQ region
Asia

Offices7 records

Markets served

Board of Radiation & Isotope Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Infrastructure, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Radiopharmaceutical Products: Sale of radiopharmaceuticals including PET products, SPECT products, therapeutic radiopharmaceuticals, and radiochemicals to hospitals and medical institutions
  2. Sealed Radiation Sources: Manufacturing and sale of sealed radiation sources including cobalt teletherapy sources, irradiator sources, and radiography sources
  3. Radiation Equipment: Sale of radiation technology equipment including gamma chambers, blood irradiators, and radiography cameras
  4. Service Operations: Sterilization of medical products, radiation processing plant services, radioanalytical laboratory services, isotope application services, EB processing services, calibration services, and dosimetry services

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goGovernment/military

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Board of Radiation & Isotope Technologies product offering

Product offering

Core offering

Board of Radiation & Isotope Technology (BRIT) manufactures and supplies radiopharmaceuticals (PET, SPECT, therapeutic, radiochemical), sealed radiation sources (cobalt-60 teletherapy, irradiator, radiography, brachytherapy), and radiation technology equipment (gamma chambers, blood irradiators, radiography cameras). The organization also provides radiation-based services including medical product sterilization, radiation processing, dosimetry, calibration, and consultancy to healthcare, agriculture, research, and industrial customers across India.

Product overview

BRIT (Board of Radiation & Isotope Technology) is an independent unit of India's Department of Atomic Energy providing a comprehensive portfolio of radiation and isotope-based products and services for healthcare, agriculture, research, and industry applications. The company's offerings include: (1) Radiopharmaceuticals for PET and SPECT imaging and therapeutic applications; (2) Radio Immunoassay Kits for hormone testing; (3) Labelled Compounds (Tritium, Carbon-14, Sulphur-35) for research; (4) Sealed Sources including Cobalt Teletherapy, Irradiator, Radiography, and Brachytherapy sources; (5) Radiation Technology Equipment including Gamma Chambers (GC 5000, GC 1200), Blood Irradiators (BI 2000), and Radiography Cameras (ROLI-2, ROLI-3, COCAM-120); (6) Dosimetry products including Ceric-Cerous Dosimeters and Biological Indicators; (7) Low Level Check Sources; and (8) Various services including medical product sterilization, radiation processing, calibration, and consultancy. The company operates regional centers in Mumbai, Bengaluru, Delhi, Dibrugarh, Hyderabad, Kolkata, and Kota.

Differentiator

Problem solved

Functional benefit

Brands

  • BRIT Bandhu: Mobile application for BRIT services and information
  • ISOMED 2.0
  • RAPPCOF (RAPS Cobalt Facility)
  • Cyclone-30

Products and services

  • Radiopharmaceuticals

Quantifiable outcome

  • 1500+ customers served across India
  • +3 more outcomes

Companies that use Board of Radiation & Isotope Technologies

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Board of Radiation & Isotope Technologies technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Board of Radiation & Isotope Technologies partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered minor and core.

  • District Project Livelihood College Society, DantewadaminorStrategic or Co-development PartnerMoU for livelihood training and skill development programs related to radiation technology applications
  • Sri Varsha Food Products India Pvt. LtdminorStrategic or Co-development PartnerMoU for food processing and radiation sterilization services
  • Fanidhar Mega Food Park Pvt. LtdminorStrategic or Co-development PartnerMoU for food irradiation and preservation services at mega food park facility
  • HK Food ParkminorStrategic or Co-development PartnerMoU for food processing radiation services
  • Tarson Products Limited, KolkataminorStrategic or Co-development PartnerMoU for Radiation Processing Plant (RPP) services
  • Q-Line HealthcareminorStrategic or Co-development PartnerMoU for healthcare sector radiation services
  • Green RadminorStrategic or Co-development PartnerMoU for radiation technology services in green/radiation applications
  • Microwin Sterisolutions Pvt. LtdminorStrategic or Co-development PartnerMoU for sterilization solutions and services
  • Vishvesh Agromed Pvt. Ltd, MaharashtraminorStrategic or Co-development PartnerMoU for agricultural and medical radiation applications
  • Hon. Balasaheb Thackeray Haridra Research and Training CenterminorStrategic or Co-development PartnerMoU for research and training in radiation technology applications
  • Poly Medicure LtdminorStrategic or Co-development PartnerMoU for medical equipment sterilization services
  • International Atomic Energy Agency (IAEA)coreStrategic or Co-development PartnerParticipation in IAEA programs including CRP projects, international conferences on radiation science and technology, and technology transfer initiatives
  • Variable Energy Cyclotron Centre (VECC), KolkatacoreTechnology or IntegrationHosting of Medical Cyclotron Facility (Cyclone-30) at VECC premises for production of PET and SPECT radioisotopes for Eastern India
  • Bhabha Atomic Research Centre (BARC)coreTechnology or IntegrationBRIT operates within BARC complex and receives technical support and isotope production from research reactors at BARC
  • Cellular and Molecular Biology Centre (CCMB), HyderabadcoreTechnology or IntegrationRegional Centre Hyderabad is located at CCMB campus for collaboration in molecular biology and biotechnology research

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Board of Radiation & Isotope Technologies competitors and assessment

Company assessment

Broad incumbents

  • Australian Nuclear Science and Technology Organisation (ANSTO): Australia's national nuclear science and technology agency, operating the OPAL reactor for Mo-99 production and producing radiopharmaceuticals, sealed sources, and irradiation services. Closest structural peer to BRIT as a government-operated multi-product nuclear technology organization with healthcare, research, and industrial mandates.
  • Lantheus Holdings: US-based radiopharmaceutical company focused on diagnostic imaging agents including SPECT and PET products. Comparable to BRIT's diagnostic radiopharmaceutical segment serving hospitals and nuclear medicine departments.
  • China Isotope & Radiation Corporation (CIRC): State-owned Chinese nuclear technology enterprise producing radiopharmaceuticals, radioactive sources, and irradiation services. Highly comparable to BRIT as a vertically integrated government-affiliated radiation technology organization serving healthcare, industry, and research within a domestic market.
  • Nordion ( Sotera Health subsidiary): Canadian-based global supplier of Cobalt-60 sealed sources, medical isotopes, and sterilization services. Directly comparable to BRIT's RAPPCOF cobalt source operations and ISOMED gamma sterilization, serving teletherapy and industrial radiography markets globally.

Direct peers

  • Curium Pharma: Global nuclear medicine company producing SPECT, PET, and therapeutic radiopharmaceuticals (including Lu-177 products). Directly comparable to BRIT's radiopharmaceutical portfolio for diagnostic imaging and cancer therapy across healthcare customers.
  • Institute of Radioelements (IRE): Belgian producer of radioisotopes (Mo-99, I-131, Lu-177) for medical and industrial applications, including sealed source manufacturing. Comparable to BRIT in Mo-99/Tc-99m generator production, therapeutic radiopharmaceuticals, and sealed radiation source manufacturing for cancer treatment and industrial radiography.
  • Eckert & Ziegler Radiopharma: German-based manufacturer of radioisotopes, radiopharmaceuticals, and radiation technology components. Comparable to BRIT's portfolio of sealed sources, calibrated radioactive reference sources, and radiopharmaceutical precursors for medical and industrial use.
  • POLATOM (National Centre for Nuclear Research): Polish national center producing radiopharmaceuticals, radioactive sources, and labelled compounds for research. Closely comparable to BRIT as a national nuclear research institute with radiopharma, sealed source, and labelled compound product lines.

Emerging players

  • SHINE Medical Technologies: US-based medical isotope producer developing Mo-99 production and therapeutic radiopharmaceuticals. Comparable to BRIT's medical radioisotope production activities for diagnostic nuclear medicine supply.
  • Telix Pharmaceuticals: Commercial-stage radiopharma company developing Ga-68 and Lu-177 based theranostic agents for prostate, kidney, and brain cancers. Comparable to BRIT's emerging Ga-68 PET and Lu-177 PSMA-617 therapeutic portfolio as a focused theranostics competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Board of Radiation & Isotope Technologies social profiles

Digital presence

Board of Radiation & Isotope Technologies compliance and trust

Trust signal

Compliance10 records

Board of Radiation & Isotope Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Board of Radiation & Isotope Technologies leadership team

Management profile

Number of profiles

Profiles10 records

Board of Radiation & Isotope Technologies subsidiaries and ownership

Company hierarchy

Subsidiaries9 records

Board of Radiation & Isotope Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Board of Radiation & Isotope Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Board of Radiation & Isotope Technologies

What does Board of Radiation & Isotope Technologies do?

Board of Radiation & Isotope Technology (BRIT) manufactures and supplies radiopharmaceuticals (PET, SPECT, therapeutic, radiochemical), sealed radiation sources (cobalt-60 teletherapy, irradiator, radiography, brachytherapy), and radiation technology equipment (gamma chambers, blood irradiators, radiography cameras). The organization also provides radiation-based services including medical product sterilization, radiation processing, dosimetry, calibration, and consultancy to healthcare, agriculture, research, and industrial customers across India.

Is Board of Radiation & Isotope Technologies a public or private company?

Board of Radiation & Isotope Technologies is a private company. It is classified as state government owned and is currently operating.

When was Board of Radiation & Isotope Technologies founded?

Board of Radiation & Isotope Technologies was founded in 1989. It employs 501 to 1,000 people.

Where is Board of Radiation & Isotope Technologies based?

Board of Radiation & Isotope Technologies is headquartered in Mumbai, India, in the Asia region.

How does Board of Radiation & Isotope Technologies make money?

Four revenue lines are on record. Radiopharmaceutical Products are the primary driver. The others are sealed Radiation Sources, radiation Equipment and service Operations.

Who are Board of Radiation & Isotope Technologies's main competitors?

Broad incumbents on record are Australian Nuclear Science and Technology Organisation (ANSTO), Lantheus Holdings, China Isotope & Radiation Corporation (CIRC) and Nordion ( Sotera Health subsidiary). Direct peers are Curium Pharma, Institute of Radioelements (IRE), Eckert & Ziegler Radiopharma and POLATOM (National Centre for Nuclear Research). Emerging players are SHINE Medical Technologies and Telix Pharmaceuticals.

Does Board of Radiation & Isotope Technologies have an API?

No public API is recorded for Board of Radiation & Isotope Technologies.

What industry is Board of Radiation & Isotope Technologies in?

Board of Radiation & Isotope Technologies's product category is Radiopharmaceuticals and Radiation Technology Products. Its primary akta.pro industry code is EUAKAIAA, Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.), with a secondary code of EUAKAIAI, Sealed Source Manufacturing, Encapsulation & Recycling/Take-Back (Source lifecycle management). Its NAICS code is 334517 and its SIC code is 3844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales